共 50 条
INTERACTION OF VIRION PROTEIN VPR OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH CELLULAR TRANSCRIPTION FACTOR SP1 AND TRANSACTIVATION OF VIRAL LONG TERMINAL REPEAT
被引:158
|作者:
WANG, LL
[1
]
MUKHERJEE, S
[1
]
JIA, FG
[1
]
NARAYAN, O
[1
]
ZHAO, LJ
[1
]
机构:
[1] UNIV KANSAS,MED CTR,DEPT MICROBIOL MOLEC GENET & IMMUNOL,VIRAL PATHOGENESIS LAB,KANSAS CITY,KS 66160
关键词:
D O I:
10.1074/jbc.270.43.25564
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
Acquired immunodeficiency syndrome (AIDS) is a result of replication of the human immunodeficiency virus type 1 (HIV-1) predominantly in CD4(+) T lymphocytes and macrophages. However, most of these cells in vivo are immunologically quiescent, a condition restricting HIV-1 replication. Vpr is an HIV-1 virion protein suspected to enhance HIV-1 replication in vivo. We demonstrate in this report that Vpr specifically activates HIV-1 long terminal repeat (LTR)-directed transcription. This effect is most pronounced on a minimal promoter from HIV-1 LTR containing the TATA box and binding motifs for the ubiquitous cellular transcription factor Sp1. Evidence is presented that Vpr interacts with Sp1 when Sp1 is bound to the Sp1 motifs within the HIV-1 LTR. Both Vpr-Sp1 interaction and Vpr trans-activation require a central Leu/Ile-rich domain in Vpr. Our findings suggest that Vpr trans-activation through Sp1 is most critical for the immediate early transcription of HIV-1 when other positive regulators, such as NF-kappa B, are Limited or inactive, a condition presumably present in vivo. By interacting with Sp1, Vpr also has the potential to influence cellular gene expression and cellular functions. Thus, therapeutic approaches directed toward blocking the Vpr trans-activation function could prove valuable in treating AIDS.
引用
收藏
页码:25564 / 25569
页数:6
相关论文